Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$197.69 - $227.29 $2,767 - $3,182
14 Added 233.33%
20 $4,000
Q2 2023

Jul 11, 2023

BUY
$211.93 - $241.33 $1,271 - $1,447
6 New
6 $1,000
Q4 2022

Jan 10, 2023

BUY
$203.72 - $248.97 $1,426 - $1,742
7 New
7 $0
Q4 2018

Jan 18, 2019

SELL
$120.82 - $174.09 $7,370 - $10,619
-61 Closed
0 $0
Q1 2018

Apr 11, 2018

SELL
$161.53 - $178.11 $323 - $356
-2 Reduced 3.17%
61 $10,000
Q4 2017

Feb 07, 2018

BUY
$147.99 - $163.95 $9,323 - $10,328
63
63 $10,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.